Canadian Urological Association (CUA) - podcast cover

Canadian Urological Association (CUA)

Canadian Urological Association / L'Association des urologues du Canadacua.simplecast.com
The official podcast of the Canadian Urological Association (CUA). Le podcast officiel de l'association des urologues du Canada (AUC).
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens

Episode Notes Podcast Host Disclosures: Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and Verity Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clin...

Mar 04, 202530 minEp. 61

Canadian Expert discussion on optimizing RCC treatment

Episode Notes Podcast Host Disclosures: Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan, Novartis, Oncohost, Pfizer, Roche, Sanofi/Aventis, Scholar Rock, Surface Oncology, Takeda, Tempest...

Nov 29, 202342 minEp. 60

2 Pees In A Pod Podcast - Ep 4 - Introduction to bladder cancer

The fourth episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features an introductory discussion on bladder cancer. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: Bladder Cancer Canada Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosi...

Oct 19, 202323 minEp. 59

2 Pees In A Pod Podcast - Ep 3 - Urinary tract infections in women

The third episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on urinary tract infections in women. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of y...

Oct 11, 202324 minEp. 58

2 Pees In A Pod Podcast - Ep 2 - Male voiding disorders and Benign Prostatic Hyperplasia (BPH)

The second episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on male voiding disorders and Benign Prostatic Hyperplasia (BPH). Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: CUA BPH Guidelines - Google Search Welcome to Canadian Urological Association | Canadian Urological Association (cua.org) Disclaimer: The information provided in ...

Oct 04, 202332 minEp. 57

2 Pees In A Pod Podcast - Ep 1 - PSA and Prostate Cancer Screening

Our inaugural 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz! This first podcast in the series focuses on PSA and Prostate Cancer Screening. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis - PMC (nih.gov) UBC & VGH Centre of Excellence | Vancouver Prostate Centre Welcom...

Sep 27, 202329 minEp. 56

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

Sponsored by Amgen. David Kendler Endocrinologist and Clinical Professor UBC Disclosures: Advisory Board: Amgen, Paladin, Biosynt Speakers Bureau: Amgen Payment: Amgen, Biosynt, Radius Pharma, Paladin Grant/Honorarium: Amgen, Biosynt, Radius Pharma, Paladin Clinical Trial: Radius Pharma Leadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)

Apr 20, 202215 minEp. 42

Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary Stones

Disclosures: Hassan Razvi Patent: Cook Urological Clinical Trials: Boston Scientific, Verity Pharma Leadership/board position: AUA, Endourology Society Olivier Traxer Consultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU

Apr 20, 20221 hr 8 minEp. 40

CUA Highlights of GU ASCO 2022 - Bladder Cancer Session - French

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosures...

Feb 22, 202243 minEp. 38

CUA Highlights of GU ASCO 2022 - Prostate Cancer Session

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, Ferring Krista Noonan Consultancy-Astellas, AstraZeneca, EMD Serono, Janssen, Pfizer Ric...

Feb 22, 202247 minEp. 34

CUA Highlights of GU ASCO 2022 - Prostate Cancer Session - French

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, Ferring Krista Noonan Consultancy-Astellas, AstraZeneca, EMD Serono, Janssen, Pfizer Ric...

Feb 22, 202247 minEp. 37

CUA Highlights of GU ASCO 2022 - Kidney Cancer Session

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, ...

Feb 22, 202249 minEp. 36

CUA Highlights of GU ASCO 2022 - Bladder Cancer Session

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosures...

Feb 22, 202243 minEp. 35

CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - French

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, ...

Feb 22, 202249 minEp. 39

V2P2 2022 - An Update in Advanced Prostate Cancer

Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant

Feb 10, 20221 hr 1 minEp. 31
For the best experience, listen in Metacast app for iOS or Android